Observational studyCancer medicine2023

Efficacy and safety of reduced-dose chemotherapy plus immunotherapy in patients with lung squamous cell carcinoma: A real-world observational study.

Ganlu Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.